Composition of amniotic fluid and maternal blood through pregnancy.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 5559265)

Published in J Obstet Gynaecol Br Commonw on June 01, 1971

Authors

T Lind, W Z Billewicz, G A Cheyne

Articles by these authors

The assessment of fetal growth. J Obstet Gynaecol Br Commonw (1968) 12.57

Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man. Gut (1983) 3.46

Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weight. Trans R Soc Trop Med Hyg (1983) 3.46

Statistical methods applied to the diagnosis of hypothyroidism. Q J Med (1969) 2.82

The energy cost of human lactation. Br J Nutr (1970) 2.15

Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther (2009) 2.11

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother (1999) 2.07

Magnetic resonance imaging pelvimetry: a useful adjunct in the management of the obese patient. Br J Obstet Gynaecol (1992) 2.02

Growth and Mortality in Children in an African Village. Br Med J (1961) 1.95

Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial. Gut (2008) 1.93

Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther (2003) 1.91

Changes in skinfolds during pregnancy. Br J Nutr (1967) 1.88

Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study. Aliment Pharmacol Ther (2011) 1.76

Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol (1999) 1.74

Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71

Growth from birth to adult life of 442 Newcastle upon Tyne children. Br J Prev Soc Med (1972) 1.70

Effects of substituted benzimidazole (H 149/94) on gastric acid secretion in humans. Gastroenterology (1982) 1.66

The weight of the placenta in relation to birthweight. J Obstet Gynaecol Br Commonw (1969) 1.65

The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther (2004) 1.64

The demography of two West African (Gambian) villages, 1951--75. J Biosoc Sci (1981) 1.60

Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. Dig Liver Dis (2006) 1.57

The epidemiology of shoulder dislocations. Arch Orthop Trauma Surg (1989) 1.53

Maternal body mass index in early pregnancy and offspring asthma, rhinitis and eczema up to 16 years of age. Clin Exp Allergy (2015) 1.53

Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Aliment Pharmacol Ther (2015) 1.51

Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study. Aliment Pharmacol Ther (2006) 1.49

Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol (2004) 1.47

Antenatal screening for diabetes mellitus. Br J Obstet Gynaecol (1984) 1.47

The health of young children in a West African (Gambian) village. Trans R Soc Trop Med Hyg (1970) 1.46

Plasma immunoglobulin concentrations in an African (Gambian) community in relation to season, malaria and other infections and pregnancy. Clin Exp Immunol (1970) 1.43

The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis. EMBO Rep (2000) 1.41

A serial study of changes occurring in the oral glucose tolerance test during pregnancy. J Obstet Gynaecol Br Commonw (1973) 1.41

Development and comorbidity of eczema, asthma and rhinitis to age 12: data from the BAMSE birth cohort. Allergy (2012) 1.41

Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther (2003) 1.40

The growth of young children in a Gambian village. Trans R Soc Trop Med Hyg (1968) 1.39

Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists. N Engl J Med (1984) 1.36

Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study. Scand J Gastroenterol (1997) 1.36

Fetal heart rate monitoring during labour--too frequent intervention, too little benefit? Lancet (1987) 1.36

Heritability of stature in a West African population. Ann Hum Genet (1978) 1.35

Body weight in parous women. Br J Prev Soc Med (1970) 1.34

A birth-to-maturity longitudinal study of heights and weights in two West African (Gambian) villages, 1951-1975. Ann Hum Biol (1982) 1.32

Red cell mass during and after normal pregnancy. Br J Obstet Gynaecol (1979) 1.28

Some implications of self-selection for pregnancy. Br J Prev Soc Med (1973) 1.27

Changes in serum uric acid concentrations during normal pregnancy. Br J Obstet Gynaecol (1984) 1.26

Plasma immunoglobulin concentrations in mothers and newborn children with special reference to placental malaria: Studies in the Gambia, Nigeria, and Switzerland. Bull World Health Organ (1973) 1.23

New index for evaluation of oral glucose tolerance test results. Br Med J (1973) 1.17

Identification that KfiA, a protein essential for the biosynthesis of the Escherichia coli K5 capsular polysaccharide, is an alpha -UDP-GlcNAc glycosyltransferase. The formation of a membrane-associated K5 biosynthetic complex requires KfiA, KfiB, and KfiC. J Biol Chem (2000) 1.16

Observations on blood glucose and insulin determinations. Br Med J (1972) 1.16

Interphotoreceptor retinoid-binding protein and alpha-tocopherol preserve the isomeric and oxidation state of retinol. Photochem Photobiol (1992) 1.15

The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther (1999) 1.13

Renal reabsorption of glucose. Lancet (1972) 1.13

Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Scand J Gastroenterol (1991) 1.12

Characterization of the glycosyltransferase enzyme from the Escherichia coli K5 capsule gene cluster and identification and characterization of the glucuronyl active site. J Biol Chem (1998) 1.11

Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs. Aliment Pharmacol Ther (2006) 1.09

Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther (2001) 1.09

The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther (1999) 1.08

Unsuspected pregnancy loss in healthy women. Lancet (1983) 1.07

Observations on the oral glucose tolerance test in pregnancy. J Obstet Gynaecol Br Commonw (1968) 1.06

Endocrine cells in the human oxyntic mucosa. A histochemical study. Scand J Gastroenterol (1988) 1.06

Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease -- results from a randomized trial programme. Aliment Pharmacol Ther (2002) 1.05

The effects of oral iron supplementation on zinc and magnesium levels during pregnancy. Br J Obstet Gynaecol (1985) 1.05

Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study. Gut (2005) 1.04

Effect of iron supplementation on serum ferritin levels during and after pregnancy. Br J Obstet Gynaecol (1982) 1.04

Biochemical and cytological changes in liquor amnii with advancing gestation. J Obstet Gynaecol Br Commonw (1969) 1.03

A longitudinal study of growth in Newcastle upon Tyne adolescents. Ann Hum Biol (1983) 1.03

The efficiency of matched samples: an empirical investigation. Biometrics (1965) 1.01

The epidemiology of oedema during pregnancy. J Obstet Gynaecol Br Commonw (1967) 1.01

Haematological changes during normal pregnancy: iron induced macrocytosis. Br J Obstet Gynaecol (1976) 1.00

Sources of variation in menstrual blood loss. J Obstet Gynaecol Br Commonw (1971) 0.99

Relation between birth-weight and rupture-delivery interval. Lancet (1969) 0.99

The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection. Helicobacter (2000) 0.97

Absorption of non-haem iron from food during normal pregnancy. BMJ (1994) 0.97

Serial hematologic changes and pregnancy outcome. Obstet Gynecol (1996) 0.97

The excretion of glucose during normal pregnancy. J Obstet Gynaecol Br Commonw (1972) 0.97

Does random blood glucose sampling outdate testing for glycosuria in the detection of diabetes during pregnancy? Br Med J (Clin Res Ed) (1984) 0.96

Pubertal changes in boys and girls in Newcastle upon Tyne. Ann Hum Biol (1981) 0.96

Metabolic changes in pregnancy relevant to diabetes mellitus. Postgrad Med J (1979) 0.95

The intravascular mass of albumin during human pregnancy: a serial study in normal and diabetic women. Br J Obstet Gynaecol (1993) 0.94

Effect of normal pregnancy upon the glycosylated haemoglobins. Br J Obstet Gynaecol (1979) 0.94

Systematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis -- a mixed treatment comparison of randomized controlled trials. Aliment Pharmacol Ther (2009) 0.93

BMI at 4 years of age is associated with previous and current protein intake and with paternal BMI. Eur J Clin Nutr (2009) 0.92

Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study. Aliment Pharmacol Ther (2009) 0.91

Antenatal screening for diabetes mellitus by random blood glucose sampling. Br J Obstet Gynaecol (1981) 0.91

Medical or surgical management of GERD patients with Barrett's esophagus: the LOTUS trial 3-year experience. J Gastrointest Surg (2008) 0.91

A prospective study to compare serum human placental lactogen and menstrual dates for determining gestational age. Am J Obstet Gynecol (1987) 0.90

Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response? Aliment Pharmacol Ther (2007) 0.90

The epidemiology of influenza in a tropical (Gambian) environment. Br Med Bull (1979) 0.90

Palliative endoscopic dilatation in carcinoma of the esophagus and esophagogastric junction. Acta Chir Scand (1989) 0.89

Plasma biochemistry in relation to oedema of pregnancy. J Obstet Gynaecol Br Commonw (1972) 0.89

Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists. Aliment Pharmacol Ther (1990) 0.89

Changes in serum immunoreactive erythropoietin during the menstrual cycle and normal pregnancy. Br J Obstet Gynaecol (1983) 0.88

Daily treatment with esomeprazole is superior to that taken on-demand for maintenance of healed erosive oesophagitis. Aliment Pharmacol Ther (2005) 0.88

Effect of adductor canal block on pain in patients with severe pain after total knee arthroplasty: a randomized study with individual patient analysis. Br J Anaesth (2014) 0.88

A prospective, controlled trial of six forms of hormone replacement therapy given to postmenopausal women. Br J Obstet Gynaecol (1979) 0.88